Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole

Abroad (travel likely)RecruitingPHASE4

Conditions

Trichomonas Vaginitis · Bacterial Vaginitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Alabama at Birmingham [UAB] Gynecology Clinics, Birmingham, Alabama, United States
Contact: Study coordinator (Stephanie Clevenger) · slangan@uabmc.edu · 205-934-0877
Janeen Arbuckle (Sub-investigator)
UAB Sexual Health Research Clinic [SHRC], Birmingham, Alabama, United States
Contact: Study coordinator (Saralyn Richter) · srichter@uabmc.edu · 205-934-8166
Contact: Principal Investigator (Christina Muzny)
Segal Trials Healthcare Clinical Data, Inc. 1065 NE 125th St. Suite 417 North Miami, FL 33161, North Miami, Florida, United States
Contact: Study coordinator (Dimary Rivera) · drivera@segaltrials.com · 305-722-8444
Steven Chavoustie (Sub-investigator)
LSU-CrescentCare Sexual Health Center, New Orleans, Louisiana, United States
Contact: Study coordinator (Catherine Cammarata) · CCamma@lsuhsc.edu · 504-568-4132
Rebecca Lillis (Sub-investigator)

Study leads

Patricia Kissinger, PhD
Principal Investigator
Tulane University

View source on ClinicalTrials.gov